GlassScriptPhysician profile
Brandon Michael Herber
NPI 1790546620
$1,420.87
in general payments reported to CMS, 2019-2025
18 companies · $851 in 2025
The $851 reported for 2025 was more than what 83% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $570 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $271.42 | 2024-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.05 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $205.53 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.71 | 2024-2025 | Jardiance |
| Pfizer INC. | $83.12 | 2024-2025 | |
| Edwards Lifesciences Corporation | $71.75 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Actelion Pharmaceuticals US, INC. | $60.27 | 2024-2025 | Opsumit, Uptravi |
| Boston Scientific Corporation | $59.44 | 2024-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $42.01 | 2024-2025 | Verquvo |
| Abiomed | $38.47 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $36.14 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $35.39 | 2025 | Eliquis, Camzyos |
| Alnylam Pharmaceuticals INC. | $32.61 | 2025 | Amvuttra |
| Esperion Therapeutics, INC. | $29.84 | 2024-2025 | Nexletol |
| Heartflow, INC. | $20.21 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $18.48 | 2024 | Arcalyst |
| Vivaquant INC, Dba Rhythm Express | $18.46 | 2025 | Rhythm Express |
| Sanofi-Aventis U.S. LLC | $14.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Herber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.